Net Cash Provided by (Used in) Operating Activities |
-60.1K |
USD |
+84% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Financing Activities |
92.2K |
USD |
-86% |
Q1 2025 |
Q1 2025 |
Net Cash Provided by (Used in) Investing Activities |
-33.6K |
USD |
+88.8% |
Q1 2025 |
Q1 2025 |
Common Stock, Shares Authorized |
26M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Shares, Issued |
2.64M |
shares |
0% |
Q2 2025 |
Q2 2025 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q2 2025 |
Q2 2025 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-199K |
USD |
+64.9% |
Q1 2023 |
Q1 2023 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
59.1K |
USD |
-29.4% |
Q2 2025 |
Q2 2025 |
Deferred Tax Assets, Valuation Allowance |
290K |
USD |
|
Q2 2025 |
Q2 2025 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Q1 2025 |
Q1 2025 |
Deferred Tax Assets, Gross |
290K |
USD |
|
Q2 2025 |
Q2 2025 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
62.3K |
USD |
-66.1% |
Q3 2023 |
Q3 2023 |
Deferred Federal Income Tax Expense (Benefit) |
-694 |
USD |
+78.4% |
Q1 2025 |
Q1 2025 |
Current Federal Tax Expense (Benefit) |
38.1K |
USD |
|
Q1 2024 |
Q1 2025 |
Interest Expense |
50K |
USD |
|
Q1 2024 |
Q1 2024 |